Gruninger Marc bought VRXA
October 28, 2026 · Form 4 insider transaction
Gruninger Marc bought 9,133 shares of Veraxa Biotech AG at $1.00 per share, a transaction worth $9.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
9,133
Price
$1.00
Total value
$9.1K
InsiderGruninger Marc
Role—
CompanyVeraxa Biotech AG (VRXA)
SecurityOrdinary Shares
Transaction codeP: Open-market purchase
Transaction dateOctober 28, 2026
Filing dateOctober 29, 2026
Shares owned after10,000
OwnershipDirect
10b5-1 planNo
AmendedNo